a study was made of the pharmacokinetic behaviour in plasma and urine of cefazolin in seven healthy volunteers following parenteral administration of sodium cefazolin ( 1250 mg ) and a sustained release formulation containing sodium cefazolin : cefazolin-dibenzylamine ( 1:4 ) at a total dose of 1250 mg , both formulations being administered over 1 week by the i.m . route .
C0700526
sodium
C0007546
cefazolin